It is not my spin, it is based on data from the research paper below. The authors analysed the R&D costs of 106 new drugs, obtained from a survey of 10 biopharmaceutical firms.
From https://www.sciencedirect.com/science/article/abs/pii/S0167629616000291?via%3Dihub
That is where the The Johns Hopkins Bloomberg School of Public Health sourced the information for their article from.
Are you able to supply the source for your costs claim?
MSB Trading - 2020, page-2789
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.09 |
Change
0.010(0.93%) |
Mkt cap ! $1.227B | |||
| Open | High | Low | Value | Volume |
| $1.08 | $1.09 | $1.07 | $682.6K | 627.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 13131 | $1.09 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.09 | 87457 | 13 |
View Market Depth
| Last trade - 10.20am 21/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.09 |
Change
0.010 ( 1.42 %) |
||||
| Open | High | Low | Volume | ||
| $1.09 | $1.09 | $1.08 | 47379 | ||
| Last updated 10.41am 21/05/2024 ? | |||||
| MSB (ASX) Chart |